Gross, Peter L <br/><br/>
New anticoagulants for treatment of venous thromboembolism.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Mar 2008 
 - 380-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.108.162677  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Anticoagulants--pharmacology<br/>Benzimidazoles--therapeutic use<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Dabigatran<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Maximum Tolerated Dose<br/>Morpholines--therapeutic use<br/>Oligosaccharides--therapeutic use<br/>Postphlebitic Syndrome--prevention & control<br/>Prognosis<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Pyridones--therapeutic use<br/>Rivaroxaban<br/>Survival Analysis<br/>Thiophenes--therapeutic use<br/>Treatment Outcome<br/>Venous Thromboembolism--diagnosis